Clinical Trial Update: Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of carfilzomib with bendamustine and dexamethasone in multiple myeloma has been terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Kyprolis (carfilzomib)
• Treanda (Bendamustine)

Snippet

Sponsor: Suzanne Lentzsch, MD | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-09-19